MedTrace Logo

Light-Therapy in the Treatment of the Acute Phase of the Bipolar Type II Depression

NCT00590265 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2024-08-07

No results posted yet for this study

Summary

The purpose of this study is to evaluate the efficacy and safety of light therapy for the treatment of bipolar type II patients relapsing into a depressive phase during autumn or winter.

Conditions

  • Bipolar Type II Disorder
  • Depression, Bipolar

Interventions

DEVICE

Northern Light Technology (SADelite lamp) bright light-therapy

10 000 lux for 30 minutes

DEVICE

Northern Light Technology (SADelite lamp) Dim light-therapy

\<100 lux for 30 minutes

Sponsors & Collaborators

  • National Alliance for Research on Schizophrenia and Depression

    collaborator OTHER

  • Douglas Mental Health University Institute

    lead OTHER

Principal Investigators

  • Serge Beaulieu, Ph.D. · McGill University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-01-31
Primary Completion
2025-06-30
Completion
2026-08-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00590265 on ClinicalTrials.gov